Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 9 tweeters

reddit: 1 Redditor

Citations

dimensions_citation: 84 Dimensions

Readers on

mendeley: 70 Mendeley

Summary Twitter Reddit Dimensions citations

So far, Dimensions has found 84 publications that cite this research output.

84

The most recent citing publications are shown below. View all 84 publications that cite this research output on Dimensions.

Differential organ-specific tumor response to first-line immune checkpoint inhibitor therapy in non-small cell lung cancer—a retrospective cohort study

Article in Translational Lung Cancer Research (February 2023)

Radiological response criteria in non-small cell lung cancer treated with immunotherapy: RECIST1.1 vs. iRECIST

Article in Journal of Radiological Review (January 2023)

PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy

Article in Frontiers in Immunology (December 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.